Insider Trading › TECH › Insiders
BIO-TECHNE Corp
TECH·Nasdaq·
United States·Insider activity
United States·Insider activity$72.43
-0.15 (-0.21%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
TECH
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TECHS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, TECH insiders filed 0 purchases ($0) and 1 sale ($320K) on the open market, by 1 insider. Newest filing May 12, 2026 (4 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by TECH insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$320KSales · 180 days
337Open-market transactions on record
1Insiders filing · 180 days
Purchases (code P) and sales (code S) of TECH common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
337 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Herr Amy E.Director | Sale | −6,636 | $48.28 | $320K | 200indirect | May 8, 2026 | May 12, 2026 | Form 4 ↗ |
| Herr Amy E.Director | Sale | −1,976 | $59.11 | $117K | 200indirect | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Nusse RoelandDirector | Sale | −17.0K | $56.36 | $960K | 44.6Kdirect | Aug 25, 2025 | Aug 27, 2025 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −17.0K | $56.21 | $958K | 44.9Kdirect | Aug 25, 2025 | Aug 27, 2025 | Form 4 ↗ |
| Herr Amy E.Director | Sale | −1,280 | $49.77 | $64K | 1,976indirect | Jun 9, 2025 | Jun 11, 2025 | Form 4 ↗ |
| Herr Amy E.Director | Sale | −1,860 | $65.96 | $123K | 1,976indirect | Feb 14, 2025 | Feb 18, 2025 | Form 4 ↗ |
| Kelderman KimChief Executive Officer · Director | Sale | −1,661 | $77.95 | $129K | 39.0Kdirect | Jan 27, 2025 | Jan 29, 2025 | Form 4 ↗ |
| Kelderman KimChief Executive Officer · Director | Sale | −11.7K | $77.19 | $906K | 40.7Kdirect | Jan 27, 2025 | Jan 29, 2025 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −16.0K | $72.10 | $1.2M | 43.4Kdirect | Aug 8, 2024 | Aug 12, 2024 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −4,000 | $83.84 | $335K | 36.6Kdirect | May 14, 2024 | May 16, 2024 | Form 4 ↗ |
| Nusse RoelandDirector | Sale | −10.4K | $76.98 | $801K | 43.1Kdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Nusse RoelandDirector | Sale | −8,939 | $80.32 | $718K | 51.9Kdirect | Aug 30, 2023 | Sep 1, 2023 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −80.0K | $88.36 | $7.1M | 1.3Mdirect | Jul 21, 2023 | Jul 25, 2023 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −322 | $83.00 | $27K | 1.1Mdirect | Jun 7, 2023 | Jun 9, 2023 | Form 4 ↗ |
| Furlow Brenda S.SVP - GENERAL COUNSEL | Sale | −7,450 | $82.12 | $612K | 26.1Kdirect | Dec 8, 2022 | Dec 9, 2022 | Form 4 ↗ |
| Furlow Brenda S.SVP - GENERAL COUNSEL | Sale | −800 | $82.01 | $66K | 26.1Kdirect | Dec 7, 2022 | Dec 9, 2022 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −8 | $380.71 | $3K | 5,502direct | Aug 11, 2022 | Aug 12, 2022 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −504 | $385.47 | $194K | 5,510direct | Aug 11, 2022 | Aug 12, 2022 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −992 | $380.15 | $377K | 6,014direct | Aug 10, 2022 | Aug 12, 2022 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −100 | $374.90 | $37K | 7,006direct | Aug 10, 2022 | Aug 12, 2022 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −900 | $373.99 | $337K | 7,106direct | Aug 10, 2022 | Aug 12, 2022 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −600 | $366.09 | $220K | 4,606direct | Jun 8, 2022 | Jun 9, 2022 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −1,000 | $364.31 | $364K | 4,606direct | Jun 7, 2022 | Jun 9, 2022 | Form 4 ↗ |
| Kummeth Charles R.CHIEF EXECUTIVE OFFICER · Director | Sale | −5,104 | $365.00 | $1.9M | 198.3Kdirect | Jun 7, 2022 | Jun 9, 2022 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Purchase | +300 | $352.55 | $106K | 10.1Kdirect | May 10, 2022 | May 11, 2022 | Form 4 ↗ |
| Kelderman KimPres. Diagnostics & Genom | Sale | −400 | $505.78 | $202K | 0direct | Nov 19, 2021 | Nov 23, 2021 | Form 4 ↗ |
| Kelderman KimPres. Diagnostics & Genom | Sale | −100 | $503.76 | $50K | 400direct | Nov 19, 2021 | Nov 23, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −401 | $506.24 | $203K | 1,318direct | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −2,535 | $505.49 | $1.3M | 1,719direct | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −8,989 | $504.39 | $4.5M | 4,254direct | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −9,043 | $503.61 | $4.6M | 13.2Kdirect | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −4,054 | $502.77 | $2.0M | 22.3Kdirect | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −400 | $505.01 | $202K | 26.3Kdirect | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −537 | $504.14 | $271K | 26.7Kdirect | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −300 | $502.99 | $151K | 27.3Kdirect | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −200 | $504.78 | $101K | 27.6Kdirect | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −700 | $504.09 | $353K | 27.8Kdirect | Nov 12, 2021 | Nov 16, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −200 | $525.10 | $105K | 10.8Kdirect | Nov 2, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −943 | $528.55 | $498K | 10.8Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,433 | $527.50 | $756K | 11.7Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −2,880 | $526.50 | $1.5M | 13.1Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −3,566 | $525.61 | $1.9M | 16.0Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −662 | $525.23 | $348K | 10.8Kdirect | Oct 29, 2021 | Nov 1, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −100 | $525.18 | $53K | 10.8Kdirect | Oct 28, 2021 | Nov 1, 2021 | Form 4 ↗ |
| Kelderman KimPres. Diagnostics & Genom | Sale | −822 | $529.04 | $435K | 0direct | Sep 22, 2021 | Sep 24, 2021 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −500 | $511.45 | $256K | 5,112direct | Sep 7, 2021 | Sep 9, 2021 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −4,600 | $510.23 | $2.3M | 5,612direct | Sep 7, 2021 | Sep 9, 2021 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −2,900 | $509.33 | $1.5M | 10.2Kdirect | Sep 7, 2021 | Sep 9, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −7 | $509.17 | $4K | 10.9Kdirect | Sep 2, 2021 | Sep 7, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −9,993 | $507.22 | $5.1M | 10.9Kdirect | Sep 2, 2021 | Sep 7, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −1,576 | $510.82 | $805K | 7,620direct | Sep 2, 2021 | Sep 7, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −5,295 | $509.67 | $2.7M | 9,196direct | Sep 2, 2021 | Sep 7, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −1,538 | $503.07 | $774K | 1,318direct | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −3,108 | $506.12 | $1.6M | 7,620direct | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −1,569 | $505.26 | $793K | 10.7Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −323 | $503.24 | $163K | 12.3Kdirect | Aug 31, 2021 | Sep 2, 2021 | Form 4 ↗ |
| Nusse RoelandDirector | Sale | −4,000 | $481.52 | $1.9M | 6,765direct | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −100 | $487.88 | $49K | 9,612direct | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −800 | $487.10 | $390K | 9,712direct | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −1,600 | $486.25 | $778K | 10.5Kdirect | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −600 | $485.03 | $291K | 12.1Kdirect | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −601 | $483.60 | $291K | 12.7Kdirect | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −299 | $481.77 | $144K | 13.3Kdirect | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −600 | $475.05 | $285K | 7,620direct | Aug 19, 2021 | Aug 23, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −1,838 | $474.12 | $871K | 8,220direct | Aug 19, 2021 | Aug 23, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −1,100 | $473.08 | $520K | 10.1Kdirect | Aug 19, 2021 | Aug 23, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −300 | $484.98 | $145K | 10.9Kdirect | Aug 9, 2021 | Aug 10, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −300 | $483.62 | $145K | 11.2Kdirect | Aug 9, 2021 | Aug 10, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −300 | $481.61 | $144K | 11.5Kdirect | Aug 9, 2021 | Aug 10, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −700 | $480.66 | $336K | 11.8Kdirect | Aug 9, 2021 | Aug 10, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −100 | $480.70 | $48K | 12.5Kdirect | Aug 9, 2021 | Aug 10, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,300 | $479.96 | $624K | 12.6Kdirect | Aug 9, 2021 | Aug 10, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,800 | $478.58 | $861K | 13.9Kdirect | Aug 9, 2021 | Aug 10, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −5,200 | $477.69 | $2.5M | 15.7Kdirect | Aug 9, 2021 | Aug 10, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −100 | $466.44 | $47K | 9,137direct | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −100 | $463.56 | $46K | 9,237direct | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −300 | $462.08 | $139K | 9,337direct | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −600 | $460.71 | $276K | 9,637direct | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −800 | $459.64 | $368K | 10.2Kdirect | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,863 | $458.81 | $855K | 11.0Kdirect | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,136 | $457.79 | $520K | 12.9Kdirect | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −527 | $456.41 | $241K | 14.0Kdirect | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,773 | $455.57 | $808K | 14.6Kdirect | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −662 | $454.15 | $301K | 16.3Kdirect | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −788 | $453.21 | $357K | 17.0Kdirect | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −751 | $451.95 | $339K | 17.8Kdirect | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −600 | $451.07 | $271K | 18.5Kdirect | Jul 12, 2021 | Jul 14, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −326 | $450.37 | $147K | 154.4Kdirect | Jun 18, 2021 | Jun 21, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −2,583 | $449.09 | $1.2M | 154.7Kdirect | Jun 18, 2021 | Jun 21, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −109 | $452.13 | $49K | 157.3Kdirect | Jun 17, 2021 | Jun 21, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −1,050 | $451.54 | $474K | 157.4Kdirect | Jun 17, 2021 | Jun 21, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −1,698 | $450.39 | $765K | 158.5Kdirect | Jun 17, 2021 | Jun 21, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −6,732 | $449.35 | $3.0M | 160.2Kdirect | Jun 17, 2021 | Jun 21, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −349 | $450.10 | $157K | 166.9Kdirect | Jun 14, 2021 | Jun 16, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −7,132 | $449.10 | $3.2M | 167.3Kdirect | Jun 14, 2021 | Jun 16, 2021 | Form 4 ↗ |
| Kelderman KimPres. Diagnostics & Genom | Sale | −811 | $433.00 | $351K | 0direct | Jun 9, 2021 | Jun 11, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −310 | $424.59 | $132K | 9,137direct | Jun 7, 2021 | Jun 9, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,700 | $423.74 | $720K | 9,447direct | Jun 7, 2021 | Jun 9, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −2,000 | $422.81 | $846K | 11.1Kdirect | Jun 7, 2021 | Jun 9, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −2,396 | $421.93 | $1.0M | 13.1Kdirect | Jun 7, 2021 | Jun 9, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −2,029 | $420.66 | $854K | 15.5Kdirect | Jun 7, 2021 | Jun 9, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,507 | $419.88 | $633K | 17.6Kdirect | Jun 7, 2021 | Jun 9, 2021 | Form 4 ↗ |
| Kelderman KimPres. Diagnostics & Genom | Sale | −845 | $424.00 | $358K | 811direct | May 25, 2021 | May 27, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −600 | $401.52 | $241K | 9,137direct | Feb 12, 2021 | Feb 17, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −9,400 | $400.32 | $3.8M | 9,737direct | Feb 12, 2021 | Feb 17, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −3,326 | $399.12 | $1.3M | 6,124direct | Feb 12, 2021 | Feb 17, 2021 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −6,674 | $398.40 | $2.7M | 9,450direct | Feb 12, 2021 | Feb 17, 2021 | Form 4 ↗ |
| Nusse RoelandDirector | Sale | −6,000 | $385.08 | $2.3M | 6,765direct | Feb 8, 2021 | Feb 10, 2021 | Form 4 ↗ |
| Kelderman KimPres. Diagnostics & Genom | Sale | −823 | $388.45 | $320K | 845direct | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −1,100 | $385.59 | $424K | 1,318direct | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −1,900 | $384.15 | $730K | 2,418direct | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −3,700 | $382.60 | $1.4M | 4,318direct | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −2,900 | $381.52 | $1.1M | 8,018direct | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −12.8K | $380.50 | $4.9M | 10.9Kdirect | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −4,500 | $379.62 | $1.7M | 23.8Kdirect | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −6,000 | $378.29 | $2.3M | 28.3Kdirect | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −20.0K | $344.00 | $6.9M | 146.3Kdirect | Jan 15, 2021 | Jan 20, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −2,009 | $334.98 | $673K | 9,137direct | Jan 11, 2021 | Jan 13, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −3,990 | $334.39 | $1.3M | 11.1Kdirect | Jan 11, 2021 | Jan 13, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −2,501 | $333.23 | $833K | 15.1Kdirect | Jan 11, 2021 | Jan 13, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −700 | $331.61 | $232K | 17.6Kdirect | Jan 11, 2021 | Jan 13, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −400 | $330.27 | $132K | 18.3Kdirect | Jan 11, 2021 | Jan 13, 2021 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −400 | $328.68 | $131K | 18.7Kdirect | Jan 11, 2021 | Jan 13, 2021 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −5,000 | $308.00 | $1.5M | 166.3Kdirect | Dec 7, 2020 | Dec 9, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −707 | $302.82 | $214K | 6,124direct | Nov 30, 2020 | Dec 2, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −6,783 | $302.15 | $2.0M | 6,831direct | Nov 30, 2020 | Dec 2, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −3,367 | $301.32 | $1.0M | 13.6Kdirect | Nov 30, 2020 | Dec 2, 2020 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −5,000 | $303.34 | $1.5M | 9,612direct | Nov 18, 2020 | Nov 20, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,100 | $307.78 | $339K | 9,137direct | Nov 11, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −6,291 | $306.93 | $1.9M | 10.2Kdirect | Nov 11, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Seth AlpnaDirector | Sale | −3,665 | $306.95 | $1.1M | 2,139direct | Nov 9, 2020 | Nov 19, 2020 | Form 4 ↗ |
| Seth AlpnaDirector | Sale | −1,358 | $305.74 | $415K | 5,804direct | Nov 9, 2020 | Nov 19, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −300 | $312.58 | $94K | 9,137direct | Nov 9, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,002 | $311.60 | $312K | 9,437direct | Nov 9, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,098 | $310.55 | $341K | 10.4Kdirect | Nov 9, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −100 | $307.74 | $31K | 11.5Kdirect | Nov 9, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,100 | $306.81 | $337K | 11.6Kdirect | Nov 9, 2020 | Nov 12, 2020 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −2,535 | $304.59 | $772K | 5,112direct | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −975 | $304.14 | $297K | 7,647direct | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −1,195 | $302.31 | $361K | 8,622direct | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −1,801 | $301.78 | $544K | 9,817direct | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −1,771 | $299.96 | $531K | 11.6Kdirect | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −1,723 | $299.06 | $515K | 13.4Kdirect | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −3,100 | $301.06 | $933K | 4,412direct | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −450 | $299.84 | $135K | 7,512direct | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −1,450 | $298.98 | $434K | 7,962direct | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −100 | $293.66 | $29K | 9,137direct | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −750 | $291.06 | $218K | 9,237direct | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −359 | $289.39 | $104K | 9,987direct | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −3,249 | $287.98 | $936K | 10.3Kdirect | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −121 | $287.15 | $35K | 13.6Kdirect | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,630 | $285.12 | $465K | 13.7Kdirect | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −325 | $283.64 | $92K | 15.3Kdirect | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,674 | $282.52 | $473K | 15.7Kdirect | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −203 | $281.27 | $57K | 17.3Kdirect | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −398 | $280.28 | $112K | 17.5Kdirect | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,200 | $275.79 | $331K | 9,137direct | Nov 4, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,600 | $274.53 | $439K | 10.3Kdirect | Nov 4, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −2,745 | $273.65 | $751K | 11.9Kdirect | Nov 4, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,555 | $272.71 | $424K | 14.7Kdirect | Nov 4, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −74 | $278.84 | $21K | 4,311direct | Jul 9, 2020 | Jul 13, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −2,746 | $278.06 | $764K | 4,385direct | Jul 9, 2020 | Jul 13, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −1,954 | $277.28 | $542K | 7,131direct | Jul 9, 2020 | Jul 13, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −400 | $276.03 | $110K | 9,085direct | Jul 9, 2020 | Jul 13, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −918 | $274.80 | $252K | 9,485direct | Jul 9, 2020 | Jul 13, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −2,042 | $273.33 | $558K | 10.4Kdirect | Jul 9, 2020 | Jul 13, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −505 | $272.48 | $138K | 12.4Kdirect | Jul 9, 2020 | Jul 13, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −440 | $270.97 | $119K | 12.9Kdirect | Jul 9, 2020 | Jul 13, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −500 | $272.26 | $136K | 9,307direct | Jul 7, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,663 | $271.40 | $451K | 9,807direct | Jul 7, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −414 | $270.56 | $112K | 11.5Kdirect | Jul 7, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,269 | $274.52 | $348K | 9,307direct | Jul 6, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,934 | $273.71 | $529K | 10.6Kdirect | Jul 6, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −4,947 | $272.34 | $1.3M | 12.5Kdirect | Jul 6, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −3,781 | $271.53 | $1.0M | 17.5Kdirect | Jul 6, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −9,571 | $270.45 | $2.6M | 21.2Kdirect | Jul 6, 2020 | Jul 8, 2020 | Form 4 ↗ |
| WIENS HAROLD JDirector | Sale | −3,985 | $260.00 | $1.0M | 4,843direct | May 29, 2020 | Jun 2, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −709 | $264.01 | $187K | 0direct | May 29, 2020 | Jun 1, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −2,100 | $262.68 | $552K | 709direct | May 29, 2020 | Jun 1, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −3,400 | $261.74 | $890K | 2,809direct | May 29, 2020 | Jun 1, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −1,700 | $260.83 | $443K | 6,209direct | May 29, 2020 | Jun 1, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −3,800 | $260.38 | $989K | 4,311direct | May 28, 2020 | Jun 1, 2020 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −2,195 | $259.72 | $570K | 8,111direct | May 28, 2020 | Jun 1, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −3,448 | $260.19 | $897K | 0direct | May 28, 2020 | Jun 1, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −4,924 | $268.41 | $1.3M | 0direct | May 22, 2020 | May 26, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −7,676 | $267.63 | $2.1M | 4,924direct | May 22, 2020 | May 26, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −900 | $268.89 | $242K | 0direct | May 21, 2020 | May 26, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −10.1K | $267.37 | $2.7M | 900direct | May 21, 2020 | May 26, 2020 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −125 | $267.94 | $33K | 9,221direct | May 21, 2020 | May 26, 2020 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −1,974 | $267.32 | $528K | 9,346direct | May 21, 2020 | May 26, 2020 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −1,601 | $266.07 | $426K | 11.3Kdirect | May 21, 2020 | May 26, 2020 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −1,300 | $265.35 | $345K | 12.9Kdirect | May 21, 2020 | May 26, 2020 | Form 4 ↗ |
| WIENS HAROLD JDirector | Sale | −4,260 | $250.00 | $1.1M | 5,221direct | May 6, 2020 | May 8, 2020 | Form 4 ↗ |
| WIENS HAROLD JDirector | Sale | −4,000 | $225.00 | $900K | 5,221direct | Apr 30, 2020 | May 4, 2020 | Form 4 ↗ |
| Eansor Norman DavidPresident-Protein Sciences | Sale | −1,387 | $198.68 | $276K | 0direct | Mar 4, 2020 | Mar 6, 2020 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −5,000 | $205.23 | $1.0M | 4,021direct | Feb 12, 2020 | Feb 14, 2020 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −10.3K | $217.28 | $2.2M | 130.0Kdirect | Jan 6, 2020 | Jan 8, 2020 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −1,741 | $218.23 | $380K | 130.0Kdirect | Jan 3, 2020 | Jan 6, 2020 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −6,258 | $217.37 | $1.4M | 131.7Kdirect | Jan 3, 2020 | Jan 6, 2020 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −92 | $221.13 | $20K | 130.0Kdirect | Jan 2, 2020 | Jan 6, 2020 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −775 | $220.28 | $171K | 130.1Kdirect | Jan 2, 2020 | Jan 6, 2020 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −9,245 | $219.32 | $2.0M | 130.9Kdirect | Jan 2, 2020 | Jan 6, 2020 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −3,282 | $218.42 | $717K | 140.1Kdirect | Jan 2, 2020 | Jan 6, 2020 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −6,449 | $217.40 | $1.4M | 143.4Kdirect | Jan 2, 2020 | Jan 6, 2020 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −471 | $222.18 | $105K | 130.0Kdirect | Dec 24, 2019 | Dec 27, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −659 | $222.08 | $146K | 130.0Kdirect | Dec 23, 2019 | Dec 27, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −5,767 | $222.06 | $1.3M | 130.0Kdirect | Dec 20, 2019 | Dec 23, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −5,767 | $222.06 | $1.3M | 130.0Kdirect | Dec 20, 2019 | Dec 23, 2019 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −200 | $216.75 | $43K | 2,711direct | Dec 12, 2019 | Dec 17, 2019 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −4,147 | $216.01 | $896K | 2,911direct | Dec 12, 2019 | Dec 17, 2019 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −3,227 | $215.17 | $694K | 7,058direct | Dec 12, 2019 | Dec 17, 2019 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −426 | $214.32 | $91K | 10.3Kdirect | Dec 12, 2019 | Dec 17, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −703 | $222.01 | $156K | 135.8Kdirect | Dec 10, 2019 | Dec 12, 2019 | Form 4 ↗ |
| WIENS HAROLD JDirector | Sale | −80 | $219.31 | $18K | 5,221direct | Dec 4, 2019 | Dec 6, 2019 | Form 4 ↗ |
| WIENS HAROLD JDirector | Sale | −921 | $218.75 | $201K | 5,301direct | Dec 4, 2019 | Dec 6, 2019 | Form 4 ↗ |
| WIENS HAROLD JDirector | Sale | −514 | $217.29 | $112K | 6,222direct | Dec 4, 2019 | Dec 6, 2019 | Form 4 ↗ |
| WIENS HAROLD JDirector | Sale | −485 | $216.47 | $105K | 6,736direct | Dec 4, 2019 | Dec 6, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −100 | $222.62 | $22K | 135.8Kdirect | Nov 29, 2019 | Dec 2, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −11.8K | $222.12 | $2.6M | 135.9Kdirect | Nov 27, 2019 | Dec 2, 2019 | Form 4 ↗ |
| Nusse RoelandDirector | Sale | −8,347 | $219.33 | $1.8M | 12.4Kdirect | Nov 25, 2019 | Nov 29, 2019 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −1,600 | $216.16 | $346K | 9,307direct | Nov 22, 2019 | Nov 25, 2019 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −22.1K | $215.55 | $4.8M | 10.9Kdirect | Nov 22, 2019 | Nov 25, 2019 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −11.3K | $215.36 | $2.4M | 9,307direct | Nov 21, 2019 | Nov 25, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Purchase | +100 | $185.00 | $19K | 100indirect | Sep 9, 2019 | Sep 11, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Purchase | +100 | $185.00 | $19K | 100indirect | Sep 9, 2019 | Sep 11, 2019 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Purchase | +500 | $191.06 | $96K | 8,726direct | Aug 7, 2019 | Aug 9, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −494 | $214.07 | $106K | 92.2Kdirect | Jul 10, 2019 | Jul 12, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −9,909 | $213.32 | $2.1M | 92.7Kdirect | Jul 10, 2019 | Jul 12, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −6,566 | $212.75 | $1.4M | 102.6Kdirect | Jul 10, 2019 | Jul 12, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −15.0K | $212.43 | $3.2M | 92.2Kdirect | Jul 9, 2019 | Jul 10, 2019 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −18.0K | $212.75 | $3.8M | 92.2Kdirect | Jul 8, 2019 | Jul 10, 2019 | Form 4 ↗ |
| Eansor Norman DavidSVP - Novus Biologicals | Sale | −3,117 | $215.00 | $670K | 0direct | Jun 12, 2019 | Jun 14, 2019 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −5,000 | $203.67 | $1.0M | 3,526direct | Jun 4, 2019 | Jun 6, 2019 | Form 4 ↗ |
| Furlow Brenda S.SVP - General Counsel | Sale | −5,400 | $200.00 | $1.1M | 2,189direct | May 24, 2019 | May 29, 2019 | Form 4 ↗ |
| Hippel JamesChief Financial Officer | Sale | −35.0K | $203.08 | $7.1M | 4,382direct | May 1, 2019 | May 2, 2019 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −5,000 | $188.47 | $942K | 7,712direct | Aug 24, 2018 | Aug 28, 2018 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −10.0K | $187.92 | $1.9M | 3,012direct | Aug 23, 2018 | Aug 27, 2018 | Form 4 ↗ |
| Dinarello Charles ADirector | Sale | −5,000 | $176.94 | $885K | 8,212direct | Aug 8, 2018 | Aug 10, 2018 | Form 4 ↗ |
| Kummeth Charles R.Chief Executive Officer · Director | Sale | −8,000 | $160.00 | $1.3M | 76.5Kdirect | Jun 7, 2018 | Jun 8, 2018 | Form 4 ↗ |
| Eansor Norman DavidSVP - Novus Biologicals | Sale | −1,136 | $145.19 | $165K | 2,266direct | May 4, 2018 | May 11, 2018 | Form 4 ↗ |
| Dinarello Charles ADirector | Sale | −2,505 | $136.36 | $342K | 8,212direct | Feb 13, 2018 | Feb 15, 2018 | Form 4 ↗ |
| Dinarello Charles ADirector | Sale | −2,495 | $135.76 | $339K | 10.7Kdirect | Feb 13, 2018 | Feb 15, 2018 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −5,000 | $130.18 | $651K | 7,712direct | Nov 1, 2017 | Nov 3, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $121.96 | $12K | 1,870direct | Oct 10, 2017 | Oct 12, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $120.94 | $12K | 1,970direct | Sep 8, 2017 | Sep 12, 2017 | Form 4 ↗ |
| HOLBROOK KAREN ADirector | Sale | −1,059 | $121.73 | $129K | 914direct | Sep 6, 2017 | Sep 8, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $114.30 | $11K | 2,070direct | Aug 10, 2017 | Aug 14, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $116.86 | $12K | 2,170direct | Jul 10, 2017 | Jul 12, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $113.62 | $11K | 2,270direct | Jun 9, 2017 | Jun 13, 2017 | Form 4 ↗ |
| Dinarello Charles ADirector | Sale | −5,000 | $111.37 | $557K | 7,473direct | May 31, 2017 | May 31, 2017 | Form 4 ↗ |
| HOLBROOK KAREN ADirector | Sale | −5,000 | $111.15 | $556K | 1,973direct | May 25, 2017 | May 30, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −1,059 | $110.01 | $117K | 2,370direct | May 22, 2017 | Jun 1, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $110.59 | $11K | 3,429direct | May 10, 2017 | May 12, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −78 | $101.13 | $8K | 3,551direct | Apr 10, 2017 | Apr 12, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −22 | $101.23 | $2K | 3,529direct | Apr 10, 2017 | Apr 12, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −21 | $107.81 | $2K | 3,629direct | Mar 10, 2017 | Mar 14, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −79 | $107.76 | $9K | 3,650direct | Mar 10, 2017 | Mar 14, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $102.60 | $10K | 3,729direct | Feb 10, 2017 | Feb 14, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $103.57 | $10K | 3,829direct | Jan 10, 2017 | Jan 12, 2017 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $108.92 | $11K | 3,929direct | Dec 9, 2016 | Dec 13, 2016 | Form 4 ↗ |
| HOLBROOK KAREN ADirector | Sale | −1,000 | $106.73 | $107K | 1,973direct | Nov 29, 2016 | Dec 1, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $105.75 | $11K | 4,029direct | Nov 16, 2016 | Nov 18, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $104.71 | $10K | 3,215direct | Oct 19, 2016 | Oct 31, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $108.91 | $11K | 3,315direct | Sep 21, 2016 | Sep 23, 2016 | Form 4 ↗ |
| Gould Kevin SSVP Clinical Controls | Sale | −524 | $110.50 | $58K | 1,667direct | Sep 8, 2016 | Sep 12, 2016 | Form 4 ↗ |
| HIGGINS JOHN LDirector | Sale | −1,700 | $109.83 | $187K | 1,359direct | Sep 8, 2016 | Sep 12, 2016 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −2,613 | $107.15 | $280K | 6,059direct | Sep 2, 2016 | Sep 6, 2016 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −3,854 | $107.18 | $413K | 6,059direct | Sep 1, 2016 | Sep 6, 2016 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −3,533 | $107.10 | $378K | 6,059direct | Aug 24, 2016 | Aug 26, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $113.70 | $11K | 3,415direct | Aug 17, 2016 | Aug 19, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $111.03 | $11K | 3,615direct | Jul 20, 2016 | Jul 21, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $112.15 | $11K | 3,715direct | Jun 15, 2016 | Jun 16, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $102.53 | $10K | 3,815direct | May 18, 2016 | May 19, 2016 | Form 4 ↗ |
| Dinarello Charles ADirector | Sale | −5,000 | $101.91 | $510K | 6,559direct | May 9, 2016 | May 10, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −500 | $100.24 | $50K | 3,915direct | May 6, 2016 | May 9, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $92.40 | $9K | 4,315direct | Apr 20, 2016 | Apr 22, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −100 | $92.90 | $9K | 4,415direct | Mar 16, 2016 | Mar 18, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −5,000 | $83.68 | $418K | 4,515direct | Feb 5, 2016 | Feb 8, 2016 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −5,000 | $106.02 | $530K | 3,456direct | Aug 17, 2015 | Aug 19, 2015 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −5,000 | $106.01 | $530K | 3,456direct | Aug 13, 2015 | Aug 17, 2015 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −1,000 | $99.39 | $99K | 1,000direct | Jun 8, 2015 | Jun 9, 2015 | Form 4 ↗ |
| OCONNELL HOWARD VDirector | Sale | −5,000 | $95.78 | $479K | 70.0Kindirect | Feb 19, 2015 | Feb 20, 2015 | Form 4 ↗ |
| HOLBROOK KAREN ADirector | Sale | −1,000 | $92.40 | $92K | 1,000direct | Dec 10, 2014 | Dec 12, 2014 | Form 4 ↗ |
| REAGAN KEVIN JSenior VP - Biotech | Sale | −2,591 | $89.32 | $231K | 0direct | Dec 9, 2014 | Dec 9, 2014 | Form 4 ↗ |
| Dinarello Charles ADirector | Sale | −3,000 | $90.44 | $271K | 4,000direct | Dec 8, 2014 | Dec 10, 2014 | Form 4 ↗ |
| REAGAN KEVIN JSenior VP - Biotech | Sale | −1,000 | $89.41 | $89K | 0direct | Dec 5, 2014 | Dec 9, 2014 | Form 4 ↗ |
| HOLBROOK KAREN ADirector | Sale | −5,000 | $95.54 | $478K | 1,000direct | Aug 14, 2014 | Aug 15, 2014 | Form 4 ↗ |
| OCONNELL HOWARD VDirector | Sale | −4,066 | $91.00 | $370K | 70.0Kindirect | May 7, 2014 | May 8, 2014 | Form 4 ↗ |
| OCONNELL HOWARD VDirector | Sale | −934 | $91.00 | $85K | 70.0Kindirect | May 6, 2014 | May 8, 2014 | Form 4 ↗ |
| HOLBROOK KAREN ADirector | Sale | −5,000 | $89.83 | $449K | 1,000direct | Mar 4, 2014 | Mar 6, 2014 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −5,000 | $88.78 | $444K | 1,000direct | Feb 27, 2014 | Feb 28, 2014 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −15.0K | $90.03 | $1.4M | 2,456direct | Feb 19, 2014 | Feb 21, 2014 | Form 4 ↗ |
| STEER RANDOLPH CDirector | Sale | −15.0K | $86.20 | $1.3M | 1,000direct | Nov 13, 2013 | Nov 15, 2013 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Sale | −10.0K | $87.00 | $870K | 4,000direct | Nov 8, 2013 | Nov 12, 2013 | Form 4 ↗ |
| LUCAS ROGER CDirector | Sale | −10.0K | $87.64 | $876K | 2,456direct | Nov 4, 2013 | Nov 5, 2013 | Form 4 ↗ |
| OCONNELL HOWARD VDirector | Purchase | +2,361 | $65.00 | $153K | 70.0Kindirect | May 6, 2013 | May 7, 2013 | Form 4 ↗ |
| OCONNELL HOWARD VDirector | Sale | −8,000 | n/c | — | 87.6Kindirect | Oct 26, 2012 | Nov 28, 2012 | Form 4 ↗ |
| VERONNEAU MARCELVP Hematology Operations | Sale | −475 | $67.57 | $32K | 34.6Kdirect | Aug 14, 2012 | Aug 16, 2012 | Form 4 ↗ |
| BAUMGARTNER ROBERT VDirector | Purchase | +1,000 | $62.61 | $63K | 3,000direct | Nov 25, 2011 | Nov 28, 2011 | Form 4 ↗ |
| VERONNEAU MARCELVP Hematology Operations | Sale | −505 | $81.20 | $41K | 34.6Kdirect | May 26, 2011 | May 31, 2011 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →